0,754  0,007  Aryl hydrocarbon receptor agonist
0,612  0,005  Calcium channel L-type activator
0,532  0,021  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,517  0,018  Interleukin antagonist
0,495  0,027  GABA C receptor rho-3 antagonist
0,435  0,057  Histamine release inhibitor
0,396  0,022  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,376  0,051  5 Hydroxytryptamine release stimulant
0,353  0,035  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,395  0,081  5 Hydroxytryptamine release inhibitor
0,378  0,069  Ulceration
0,307  0,010  Interleukin 1 antagonist
0,337  0,040  Dyrk kinase inhibitor
0,297  0,004  MAP kinase kinase 4 inhibitor
0,372  0,087  Analgesic, non-opioid
0,286  0,009  Interleukin 1b antagonist
0,283  0,007  GABA C receptor rho-2 antagonist
0,365  0,092  Antineoplastic (breast cancer)
0,332  0,059  Antineoplastic (melanoma)
0,272  0,013  Glutamate receptor antagonist
0,299  0,044  Ca2+/calmodulin-dependent protein kinase inhibitor
0,274  0,022  Growth factor agonist
0,261  0,013  Age-related macular degeneration treatment
0,336  0,089  CYP2C9 inhibitor
0,316  0,077  Calcium channel activator
0,244  0,005  GABA receptor antagonist
0,248  0,015  Gout treatment
0,235  0,005  GABA A receptor antagonist
0,381  0,151  Antiinflammatory
0,293  0,063  Insulysin inhibitor
0,266  0,037  Antimigraine
0,248  0,030  Antineoplastic (gastric cancer)
0,287  0,072  FMO3 substrate
0,323  0,116  15-Lipoxygenase inhibitor
0,208  0,007  GABA C receptor rho-1 antagonist
0,215  0,015  GABA receptor agonist
0,208  0,012  Antineoplastic alkaloid
0,316  0,123  Antibacterial
0,255  0,064  Tyrosine 3 hydroxylase inhibitor
0,239  0,053  Osteoarthritis treatment
0,315  0,130  Analgesic
0,276  0,093  Hepatic disorders treatment
0,263  0,080  Renal disease treatment
0,249  0,075  Antineoplastic (cervical cancer)
0,217  0,044  Thrombolytic
0,226  0,053  Pneumotoxic
0,181  0,012  Protein kinase C delta inhibitor
0,184  0,014  Antineoplastic (uterine cancer)
0,203  0,034  CDC-like kinase 1 inhibitor
0,236  0,069  UGT1A6 substrate
0,182  0,016  Uric acid excretion stimulant
0,230  0,068  Pyruvate kinase inhibitor
0,240  0,081  Superoxide dismutase inhibitor
0,272  0,117  Antineoplastic (endocrine cancer)
0,193  0,039  Tubulin antagonist
0,196  0,045  Cystic fibrosis treatment
0,157  0,007  Benzodiazepine agonist
0,266  0,118  Antineoplastic (small cell lung cancer)
0,167  0,022  GABA C receptor antagonist
0,168  0,023  Protein kinase C gamma inhibitor
0,199  0,057  Lipocortins synthesis antagonist
0,213  0,074  Anticonvulsant
0,172  0,035  Antifungal (Cryptococcus)
0,185  0,048  Antiparkinsonian, tremor relieving
0,153  0,019  Alcohol dehydrogenase inhibitor
0,138  0,004  GABA B receptor antagonist
0,240  0,108  Antihypoxic
0,223  0,091  DNA synthesis inhibitor
0,159  0,028  NAT2 substrate
0,275  0,149  CYP2C19 inhibitor
0,215  0,095  Acute neurologic disorders treatment
0,134  0,015  Phenylalanine 4-hydroxylase inhibitor
0,172  0,058  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,148  0,034  GABA C receptor agonist
0,132  0,020  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,132  0,021  MAP-kinase-activated kinase inhibitor
0,228  0,119  CYP1A2 substrate
0,219  0,110  Radioprotector
0,163  0,056  Antidiabetic (type 1)
0,124  0,018  MAP-kinase-activated kinase 2 inhibitor
0,189  0,084  5 Hydroxytryptamine 3E antagonist
0,143  0,039  Interleukin 8 antagonist
0,170  0,067  Death-associated protein kinase 2 inhibitor
0,174  0,071  3C-like protease (Human coronavirus) inhibitor
0,161  0,059  Antineoplastic (squamous cell carcinoma)
0,188  0,086  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,170  0,069  Peroxidase inhibitor
0,139  0,039  Xanthine oxidase inhibitor
0,154  0,054  MAP3K9 inhibitor
0,210  0,110  Antineoplastic (sarcoma)
0,121  0,024  GABA A receptor agonist
0,282  0,185  Apoptosis agonist
0,166  0,069  Prostate disorders treatment
0,202  0,105  Antineoplastic (liver cancer)
0,130  0,036  Adenylate kinase inhibitor
0,294  0,200  Caspase 9 stimulant
0,104  0,014  Prostaglandin E2 antagonist
0,178  0,088  Cytotoxic
0,103  0,016  Protein kinase C eta inhibitor
0,109  0,025  Glycine receptor antagonist
0,225  0,142  Antineoplastic (lung cancer)
0,122  0,043  DOPA decarboxylase inhibitor
0,097  0,019  GABA B receptor agonist
0,138  0,060  Liver cirrhosis treatment
0,183  0,108  Cyclic AMP phosphodiesterase inhibitor
0,080  0,005  Prostaglandin EP1 antagonist
0,136  0,064  Interleukin 4 antagonist
0,171  0,099  Psychostimulant
0,118  0,048  Beta glucuronidase inhibitor
0,100  0,036  Porphobilinogen synthase inhibitor
0,079  0,017  AMPA receptor antagonist
0,150  0,089  Mcl-1 antagonist
0,216  0,155  Multiple sclerosis treatment
0,096  0,037  Somatostatin 1 agonist
0,093  0,034  Glutamate decarboxylase inhibitor
0,074  0,016  Aconitate hydratase inhibitor
0,073  0,015  NMDA receptor subunit 3B antagonist
0,056  0,001  Insulin like growth factor 3 antagonist
0,162  0,111  Antimitotic
0,113  0,064  Cyclin-dependent kinase 5 inhibitor
0,132  0,084  Antineoplastic (carcinoma)
0,140  0,092  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,158  0,112  Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor
0,093  0,047  Arylamine N-Acetyltransferase substrate
0,173  0,128  Antineoplastic (non-small cell lung cancer)
0,060  0,015  Benzodiazepine inverse agonist
0,095  0,053  Triose-phosphate isomerase inhibitor
0,129  0,086  Aurora-C kinase inhibitor
0,078  0,036  Protein kinase C alpha inhibitor
0,191  0,149  Radiosensitizer
0,071  0,030  Bombesin 1 receptor agonist
0,191  0,151  CYP2D6 substrate
0,176  0,136  Antioxidant
0,066  0,028  Protein kinase C theta inhibitor
0,076  0,037  Protein kinase C beta inhibitor
0,091  0,053  Interleukin 5 antagonist
0,055  0,018  NMDA receptor subunit 3A antagonist
0,065  0,029  Prostaglandin antagonist
0,046  0,010  AMPA 3 receptor antagonist
0,129  0,093  Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor
0,215  0,181  CYP2C9 substrate
0,081  0,048  Glutamate (mGluR) antagonist
0,045  0,013  AMPA 1 receptor antagonist
0,138  0,108  Nitric oxide antagonist
0,100  0,071  Ferrochelatase inhibitor
0,042  0,014  AMPA 2 receptor antagonist
0,101  0,073  Excitatory amino acid transporter EAAC1 inhibitor
0,088  0,061  Antidote, mercury
0,063  0,036  Xanthine dehydrogenase inhibitor
0,142  0,116  Platelet adhesion inhibitor
0,105  0,079  Photosensitizer
0,172  0,148  RNA-directed DNA polymerase inhibitor
0,164  0,141  Antineoplastic (renal cancer)
0,070  0,048  I kappa B kinase 1 inhibitor
0,152  0,130  Insulin sensitizer
0,026  0,005  Vesicular glutamate transport inhibitor
0,122  0,102  Corneal wound healing stimulator
0,174  0,154  Antineoplastic (colorectal cancer)
0,036  0,017  Protein kinase C beta I inhibitor
0,218  0,200  Rheumatoid arthritis treatment
0,127  0,109  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,131  0,114  Ca2+-transporting ATPase inhibitor
0,183  0,168  UGT2B4 substrate
0,085  0,070  HIV-1 integrase (Overall Integration) inhibitor
0,040  0,026  AMPA 4 receptor antagonist
0,165  0,151  DNA damaging
0,023  0,011  Somatostatin 3 antagonist
0,079  0,067  NMDA receptor antagonist
0,027  0,016  Kainate receptor 4 antagonist
0,051  0,040  5 Hydroxytryptamine 1B agonist
0,039  0,028  Retinoic acid alpha receptor agonist
0,037  0,028  Somatostatin 1 antagonist
0,194  0,184  Ca2+/calmodulin-dependent kinase IV inhibitor
0,174  0,167  Prostate cancer treatment
0,071  0,064  Keratolytic
0,161  0,154  Antineoplastic (colon cancer)
0,166  0,161  Antihypotensive
0,029  0,024  Somatostatin 5 antagonist
0,191  0,187  Vasodilator, peripheral
0,150  0,146  Antineoplastic (lymphoma)
0,036  0,033  Kainate receptor antagonist
0,038  0,035  Sphingosine 1-phosphate receptor 1 agonist
0,094  0,092  Topoisomerase II inhibitor
0,033  0,032  Bombesin 1 receptor antagonist
0,018  0,017  Kainate receptor 5 antagonist
0,024  0,023  Thyroid hormone agonist
0,021  0,021  NMDA receptor glycine site antagonist

